In last seven years, pharmaceutical companies have made big bets on new molecules, especially in the field of biotechnology pharma. Moreover, due to the increasing prevalence of rare disease such as genetic disorders in last five years, drug research and development institutes will be primarily focusing in biotech and pharma majorly.
Driven by increasing R&D; expenditure across the globe, we estimate that pharmaceutical industry is likely to reach $1.3 trillion by 2018. Companies are investing in technologies to help address certain challenges in therapies like reducing pain through injection or improving patient experience. Increasing number of chronic cases across the globe has resulted in pharmaceutical industry pairing connected devices with treatment regime to improve medication adherence. Focusing on these trends our reports under pharmaceutical domain such as global drug discovery market., global glucosamine market, global carotenoids market, and global multi infarct market are aimed to provide detailed insight on pharmaceutical industry growth. Our reports are primarily focusing on drug development in high investment areas such as cancer, cardiovascular diseases and dementia. Extensive primary research is being conducted among fortune 500 companies and key opinion leaders from pharmaceutical industry. We are covering key market insights from top pharma companies such as Novartis, Pfizer, Roche, Sanofi and so on.
Each report under pharmaceutical domain is supported with various macro and micro economic factors impacting pharmaceutical industry. At Occams, we skim through epidemiological data and provide an overview of the increasing disease prospects on a regional basis. With increasing number of patients, provides good business opportunity for companies to invest in medium especially in emerging economies. Our reports are updated with changing healthcare policies and offer insight depending on client’s requirement. We offer clarity towards pricing analysis of pharmaceutical drugs and therapies, through primary and secondary research.
Our reports also covers the challenges. in the pharmaceutical industry and are provided with desired strategies to overcome these challenges. One of the major challenges the industry is facing is expiration of patents, which is leading to market consolidation.
Consolidation amongst the industry players has increased over the years with rising competition and increasing drug research costs. In 2015 more than 200 partnership programs were signed between companies for drug research and development. Collaboration with universities and research institutes for research has gained priority in last five years. However, in coming years also, merger & acquisition is expected to be the primary strategy for acquiring market share. Our business research reports under pharmaceutical domain tracks all the strategies that have been followed by the key players in the respective market. Detailed analysis of the market competition has been provided in the reports. Competitive models such as porter five force analysis, patent analysis, and industry structure analysis are aimed to provide detailed analysis of pharmaceutical market structure.
The insights on changing regulatory environment and policies from government. Pharmaceutical market research reports from Occam’s include strategic analysis like 360-degree analysis, porters five force model and key buying criteria. Our analysts provide a snapshot of industry structure and present regulatory framework guiding pharmaceutical market throughout the world. Analysts carry out regional analysis on niche markets in pharmaceutical sector citing future investing possibilities, trends via PESTLE analysis for each region. Regional analysis provide analysis of leading manufacturers within a given region and their strategies. Our analysts are constantly on lookout for new therapies and treatment regime that can eclipse existing ones and worth investing in next five years.
Some of the top reports on pharmaceutical sector from our analysts are global in vitro fertilization market, global ophthalmic drug & devices market, global hyperphosphatemia drug market, global drug allergy diagnostics and therapeutics market, global multi infarct dementia market and global ortho biological products market.
